Phần 2. Cập nhật thông tin và tổng hợp y văn về tình hình bệnh nhiễm trùng do virus Ebola
Tiếp theo Phần 1: Cập nhật thông tin và tổng hợp y văn về tình hình bệnh nhiễm trùng do virus Ebola Nhiễm virus Ebola là một trong những nhiễm trùng nguy hiểm nhất, gây biến chứng và tử vong cao. Ngày 31/5, Bộ Y tế tổ chức họp đánh giá tình hình dịch bệnh Ebola để xác định nguy cơ dịch xâm nhập vào nước ra cũng như đề xuất phương án phòng chống dịch tại Việt Nam. Theo thông tin từ Cơ quan đầu mối quốc gia thực hiện Điều lệ Y tế quốc tế và đại diện Tổ chức Y tế thế giới TCYTTG), dịch bệnh Ebola tái bùng phát tại Congo từ đầu tháng 4/2018, đến ngày 29/5 đã ghi nhận 58 trường hợp nghi ngờ mắc bệnh Ebola, trong đó có 27 trường hợp tử vong (tỷ lệ chết/mắc 47%). Có 35 trường hợp xác định, 23 trường hợp nghi ngờ, trong đó có 3 trường hợp là nhân viên y tế. Các trường hợp mắc tập trung tại 3 huyện: Bikoro, Iboko và Wangata. Đây là khu vực hẻo lánh cách xa thủ đô Kinshasa, có ít khách du lịch và có điều kiện đi lại khó khăn, phương tiện đi lại từ thủ đô Kinshasa đến khu vực này chủ yếu là bằng máy bay trực thăng. Hiện tại, các quốc gia lân cận và các quốc gia khác chưa ghi nhận trường hợp bệnh Ebola. Căn cứ tình hình dịch bệnh Ebola tại Congo, thời gian tới khả năng xâm nhập dịch bệnh Ebola từ Congo vào nước ta là thấp. Do dịch bệnh Ebola chủ yếu xảy ra tại khu vực hẻo lánh của Congo, sự giao lưu thương mại giữa Việt Nam và Congo hiện rất ít song không loại trừ có thể ghi nhận trường hợp bệnh Ebola về từ vùng có dịch vào nước nước ta. Để chủ động ngăn ngừa dịch bệnh Ebola xâm nhập vào nước ta , cuộc họp đã thống nhất cần tiếp tục đẩy mạnh triển khai giám sát tại cửa khẩu và tại các bệnh viện nhằm phát hiện sớm trường hợp nghi ngờ mắc bệnh Ebola.
Hình 1-2-3
Ebola virus pathogenesis: implications for vaccines and therapies.
Sullivan N, Yang ZY, Nabel GJ.
J Virol . 2003 Sep;77(18):9733-7. Review. No abstract available.
PMID: 12941881 Free PMC Article Similar articles Select item 11597453 2.
The pathogenesis of Ebola hemorrhagic fever.
Takada A, Kawaoka Y.
Trends Microbiol . 2001 Oct;9(10):506-11. Review.
PMID: 11597453 Similar articles Select item 12974482 3.
Ebola virus: from discovery to vaccine.
Feldmann H, Jones S, Klenk HD, Schnittler HJ.
Nat Rev Immunol . 2003 Aug;3(8):677-85. Review.
PMID: 12974482 Similar articles Select item 11400662 4.
[Hope for a vaccine against ebola virus].
Holzgrabe U.
Pharm Unserer Zeit . 2001;30(3):185-6. German. No abstract available.
PMID: 11400662 Similar articles Select item 14711361 5.
Towards a vaccine against Ebola virus.
Geisbert TW, Jahrling PB.
Expert Rev Vaccines . 2003 Dec;2(6):777-89. Review.
PMID: 14711361 Similar articles Select item 16015361 6.
A single shot against Ebola and Marburg virus.
Baize S.
Nat Med . 2005 Jul;11(7):720-1. No abstract available.
PMID: 16015361 Similar articles Select item 16616875 7.
Ebola virus: unravelling pathogenesis to combat a deadly disease.
Hoenen T, Groseth A, Falzarano D, Feldmann H.
Trends Mol Med . 2006 May;12(5):206-15. Epub 2006 Apr 17. Review.
PMID: 16616875 Similar articles Select item 11766882 8.
Ebola virus: the search for vaccines and treatments.
Wilson JA, Bosio CM, Hart MK.
Cell Mol Life Sci . 2001 Nov;58(12-13):1826-41. Review.
PMID: 11766882 Similar articles Select item 12904747 9.
Fast vaccine offers hope in battle with Ebola.
Clarke T, Knight J.
Nature . 2003 Aug 7;424(6949):602. No abstract available.
PMID: 12904747 Similar articles Select item 9427596 10.
Ebola takes a punch.
Folks T.
Nat Med . 1998 Jan;4(1):16-7. No abstract available.
PMID: 9427596 Similar articles Select item 17107278 11.
Progress towards the treatment of Ebola haemorrhagic fever.
Ströher U, Feldmann H.
Expert Opin Investig Drugs . 2006 Dec;15(12):1523-35. Review.
PMID: 17107278 Similar articles Select item 21987780 12.
Filovirus infection of STAT-1 knockout mice.
Raymond J, Bradfute S, Bray M.
J Infect Dis . 2011 Nov;204 Suppl 3:S986-90. doi: 10.1093/infdis/jir335.
PMID: 21987780 Similar articles Select item 10190013 13.
[Effects of repeated administration of Ebola virus preparations on dynamics of immunologic parameters].
Chepurnov AA, Dadaeva AA, Sizikova LP.
Biull Eksp Biol Med . 1999 Jan;127(1):81-5. Russian. No abstract available.
PMID: 10190013 Similar articles Select item 17952040 14.
Immunopathology of highly virulent pathogens: insights from Ebola virus.
Zampieri CA, Sullivan NJ, Nabel GJ.
Nat Immunol . 2007 Nov;8(11):1159-64. Review.
PMID: 17952040 Similar articles Select item 11853394 15.
Evidence against an important role for infectivity-enhancing antibodies in Ebola virus infections.
Geisbert TW, Hensley LE, Geisbert JB, Jahrling PB.
Virology . 2002 Feb 1;293(1):15-9.
PMID: 11853394 Free Article Similar articles Select item 15383160 16.
Ebola virus: new insights into disease aetiopathology and possible therapeutic interventions.
Geisbert TW, Hensley LE.
Expert Rev Mol Med . 2004 Sep 21;6(20):1-24. Review.
PMID: 15383160 Similar articles Select item 12904795 17.
Accelerated vaccination for Ebola virus haemorrhagic fever in non-human primates.
Sullivan NJ, Geisbert TW, Geisbert JB, Xu L, Yang ZY, Roederer M, Koup RA, Jahrling PB, Nabel GJ.
Nature . 2003 Aug 7;424(6949):681-4.
PMID: 12904795 Similar articles Select item 25622440 18.
Battling Ebola: the virus and the fear.
Fauci A, Kresge KJ.
IAVI Rep . 2014;18(4):11-3. No abstract available.
PMID: 25622440 Free Article Similar articles Select item 11996686 19.
Evaluation in nonhuman primates of vaccines against Ebola virus.
Geisbert TW, Pushko P, Anderson K, Smith J, Davis KJ, Jahrling PB.
Emerg Infect Dis . 2002 May;8(5):503-7.
PMID: 11996686 Free PMC Article Similar articles Select item 12091886 20.
Ebola vaccine gets corporate backer.
Dove A.
Nat Med . 2002 Jul;8(7):645-6. No abstract available.
PMID: 12091886 Similar articles
Do therapeutic antibodies hold the key to an effective treatment for Ebola hemorrhagic fever?
Takada A.
Immunotherapy . 2013 May;5(5):441-3. doi: 10.2217/imt.13.29. No abstract available.
PMID: 23638738 Similar articles Select item 11222689 22.
Protection from Ebola virus mediated by cytotoxic T lymphocytes specific for the viral nucleoprotein.
Wilson JA, Hart MK.
J Virol . 2001 Mar;75(6):2660-4.
PMID: 11222689 Free PMC Article Similar articles Select item 11184732 23.
Emerging diseases. on the trail of Ebola and Marburg viruses.
Balter M.
Science . 2000 Nov 3;290(5493):923-5. No abstract available.
PMID: 11184732 Similar articles
Select item 12782057 24.
Vaccine research efforts for filoviruses.
Hart MK.
Int J Parasitol . 2003 May;33(5-6):583-95. Review.
PMID: 12782057 Similar articles Select item 11927920 25.
Ebola: small, but real progress.
Birmingham K, Cooney S.
Nat Med . 2002 Apr;8(4):313. No abstract available.
PMID: 11927920 Similar articles Select item 25635120 26.
Large-scale convalescent blood and plasma transfusion therapy for Ebola virus disease.
Colebunders RL, Cannon RO.
J Infect Dis . 2015 Apr 15;211(8):1208-10. doi: 10.1093/infdis/jiv043. Epub 2015 Jan 29. No abstract available.
PMID: 25635120 Similar articles Select item 9427604 27.
Immunization for Ebola virus infection.
Xu L, Sanchez A, Yang Z, Zaki SR, Nabel EG, Nichol ST, Nabel GJ.
Nat Med . 1998 Jan;4(1):37-42.
PMID: 9427604 Similar articles Select item 14615510 28.
Virology. New vaccine and treatment excite Ebola researchers.
Enserink M.
Science . 2003 Nov 14;302(5648):1141-2. No abstract available.
PMID: 14615510 Similar articles Select item 21695865 29.
Ebola and Marburg hemorrhagic fever viruses: update on filoviruses.
Leroy E, Baize S, Gonzalez JP.
Med Trop (Mars) . 2011 Apr;71(2):111-21. Review. French.
PMID: 21695865 Similar articles Select item 17940977 30.
Hình 4-5-6
Assessment of a vesicular stomatitis virus-based vaccine by use of the mouse model of Ebola virus hemorrhagic fever.
Jones SM, Stroher U, Fernando L, Qiu X, Alimonti J, Melito P, Bray M, Klenk HD, Feldmann H.
J Infect Dis . 2007 Nov 15;196 Suppl 2:S404-12.
PMID: 17940977 Similar articles Select item 11217674 31.
Experimental vaccine protects monkeys against Ebola virus.
Gottlieb S.
Bull World Health Organ . 2001;79(1):79. Epub 2003 Nov 5. No abstract available.
PMID: 11217674 Free PMC Article Similar articles Select item 18692765 32.
Ebola images emerge from the cave.
Diamond MS, Fremont DH.
Cell Host Microbe . 2008 Aug 14;4(2):87-9. doi: 10.1016/j.chom.2008.07.011.
PMID: 18692765 Free Article Similar articles Select item 12922144 33.
Comparison of individual and combination DNA vaccines for B. anthracis, Ebola virus, Marburg virus and Venezuelan equine encephalitis virus.
Riemenschneider J, Garrison A, Geisbert J, Jahrling P, Hevey M, Negley D, Schmaljohn A, Lee J, Hart MK, Vanderzanden L, Custer D, Bray M, Ruff A, Ivins B, Bassett A, Rossi C, Schmaljohn C.
Vaccine . 2003 Sep 8;21(25-26):4071-80.
PMID: 12922144 Similar articles Select item 12186901 34.
Hình 7
Induction of immune responses in mice and monkeys to Ebola virus after immunization with liposome-encapsulated irradiated Ebola virus: protection in mice requires CD4(+) T cells.
Rao M, Bray M, Alving CR, Jahrling P, Matyas GR.
J Virol . 2002 Sep;76(18):9176-85.
PMID: 12186901 Free PMC Article Similar articles Select item 10698744 35.
Epitopes involved in antibody-mediated protection from Ebola virus.
Wilson JA, Hevey M, Bakken R, Guest S, Bray M, Schmaljohn AL, Hart MK.
Science . 2000 Mar 3;287(5458):1664-6.
PMID: 10698744 Free Article Similar articles Select item 9333167 36.
International Colloquium on Ebola Virus Research: summary report.
Breman JG, van der Groen G, Peters CJ, Heymann DL.
J Infect Dis . 1997 Oct;176(4):1058-63. No abstract available.
PMID:9333167 Similar articles Select item 15049337 37.
[An effective vaccine against Ebola hemorrhagic fever].
Pospísil L.
Vnitr Lek . 2004 Jan;50(1):76. Czech. No abstract available.
PMID:15049337 Similar articles Select item 12805454 38.
Hình 8
Antibody-dependent enhancement of Ebola virus infection.
Takada A, Feldmann H, Ksiazek TG, Kawaoka Y.
J Virol . 2003 Jul;77(13):7539-44.
PMID: 12805454 Free PMC Article Similar articles Select item 16375711 39.
Ebola and Marburg viruses: pathogenesis and development of countermeasures.
Hensley LE, Jones SM, Feldmann H, Jahrling PB, Geisbert TW.
Curr Mol Med . 2005 Dec;5(8):761-72. Review.
PMID: 16375711 Similar articles Select item 17038820 40.
[Properties of the Ebola virus glycoprotein].
Takada A.
Uirusu . 2006 Jun;56(1):117-24. Review. Japanese.
PMID: 17038820 Free Article Similar articles
Ebola virus-like particles protect from lethal Ebola virus infection.
Warfield KL, Bosio CM, Welcher BC, Deal EM, Mohamadzadeh M, Schmaljohn A, Aman MJ, Bavari S.
Proc Natl Acad Sci U S A . 2003 Dec 23;100(26):15889-94. Epub 2003 Dec 12.
PMID: 14673108 Free PMC Article Similar articles Select item 15896665 42.
Ebola virus: the role of macrophages and dendritic cells in the pathogenesis of Ebola hemorrhagic fever.
Bray M, Geisbert TW.
Int J Biochem Cell Biol . 2005 Aug;37(8):1560-6. Epub 2005 Mar 7.
PMID: 15896665 Similar articles Select item 14694127 43.
Persistent infection with ebola virus under conditions of partial immunity.
Gupta M, Mahanty S, Greer P, Towner JS, Shieh WJ, Zaki SR, Ahmed R, Rollin PE.
J Virol . 2004 Jan;78(2):958-67.
PMID: 14694127 Free PMC Article Similar articles Select item 16501083 44.
Hình 9
Development of a cAdVax-based bivalent ebola virus vaccine that induces immune responses against both the Sudan and Zaire species of Ebola virus.
Wang D, Raja NU, Trubey CM, Juompan LY, Luo M, Woraratanadharm J, Deitz SB, Yu H, Swain BM, Moore KM, Pratt WD, Hart MK, Dong JY.
J Virol . 2006 Mar;80(6):2738-46.
PMID: 16501083 Free PMC Article Similar articles Select item 25995250 45.
Rethinking the Response to Emerging Microbes: Vaccines and Therapeutics in the Ebola Era--a Conference at Harvard Medical School.
Knipe DM, Whelan SP.
J Virol . 2015 Aug;89(15):7446-8. doi: 10.1128/JVI.01251-15. Epub 2015 May 20.
PMID: 25995250 Free PMC Article Similar articles Select item 15624463 46.
[Viral hemorrhagic fevers--Ebola hemorrhagic fever, Marburg virus disease, and Lassa fever].
Taniguchi K.
Nihon Naika Gakkai Zasshi . 2004 Nov 10;93(11):2303-8. Review. Japanese. No abstract available.
PMID: 15624463 Similar articles Select item 9004731 47.
[Ebola: "a fatal syndrome"].
Martínez GA, Ramírez Ronda CH.
Bol Asoc Med P R . 1996 Jul-Sep;88(7-9):69-72. Review. Spanish.
PMID: 9004731 Similar articles Select item 21925552 48.
Progress in recombinant DNA-derived vaccines for Lassa virus and filoviruses.
Grant-Klein RJ, Altamura LA, Schmaljohn CS.
Virus Res . 2011 Dec;162(1-2):148-61. doi: 10.1016/j.virusres.2011.09.005. Epub 2011 Sep 10. Review.
PMID: 21925552 Similar articles Select item 12718026 49.
Hình 10
[Ebola virus and Marburg virus].
Morikawa S.
Nihon Rinsho . 2003 Mar;61 Suppl 3:544-9. Review. Japanese. No abstract available.
PMID: 12718026 Similar articles Select item 25509993 50.
[Therapeutic use of immune sera. Ebola survivors as lifesavers?].
Eickmann M, Schumacher B.
MMW Fortschr Med . 2014 Nov 6;156(19):6. German. No abstract available.
PMID: 25509993 Similar articles Select item 9988187 51.
Preparation and use of hyperimmune serum for prophylaxis and therapy of Ebola virus infections.
Kudoyarova-Zubavichene NM, Sergeyev NN, Chepurnov AA, Netesov SV.
J Infect Dis . 1999 Feb;179 Suppl 1:S218-23.
PMID: 9988187 Similar articles Select item 25695274 52.
Treatment of Ebola virus infection with antibodies from reconvalescent donors.
Kreil TR.
Emerg Infect Dis . 2015 Mar;21(3):521-3. doi: 10.3201/eid2103.141838.
PMID: 25695274 Free PMC Article Similar articles Select item 20671437 53.
Recent advances in Ebolavirus vaccine development.
Richardson JS, Dekker JD, Croyle MA, Kobinger GP.
Hum Vaccin . 2010 Jun;6(6):439-49. Epub 2010 Jun 1. Review.
PMID: 20671437 Similar articles Select item 15487661 54.
An uncertain defense. How do you test that a human Ebola vaccine works? You don't.
Gibbs WW.
Sci Am . 2004 Oct;291(4):20, 24. No abstract available.
PMID: 15487661 Similar articles Select item 20513546 55.
Ebola and marburg hemorrhagic fever.
Hartman AL, Towner JS, Nichol ST.
Clin Lab Med . 2010 Mar;30(1):161-77. doi: 10.1016/j.cll.2009.12.001. Review.
PMID: 20513546 Similar articles Select item 11117750 56.
Development of a preventive vaccine for Ebola virus infection in primates.
Sullivan NJ, Sanchez A, Rollin PE, Yang ZY, Nabel GJ.
Nature . 2000 Nov 30;408(6812):605-9.
PMID: 11117750 Similar articles Select item 14745371 57.
Conference report - I. Investigating new vaccines: Ebola and HIV: highlights from the Viral Vaccine Meeting; October 25-28, 2003; Barcelona, Spain.
Armandola E.
MedGenMed . 2003 Dec 3;5(4):24. No abstract available.
PMID: 14745371 Free Article Similar articles Select item 11117724 58.
Fighting the Ebola virus.
Burton DR, Parren PW.
Nature . 2000 Nov 30;408(6812):527-8. No abstract available.
PMID: 11117724 Similar articles Select item 12152882 59.
Study of the pathogenesis of Ebola fever in laboratory animals with different sensitivity to this virus.
Chepurnov AA, Dadaeva AA, Kolesnikov SI.
Bull Exp Biol Med . 2001 Dec;132(6):1182-6.
PMID: 12152882 Similar articles Select item 9717212 60.
Pathogenesis of Ebola virus infection: recent insights.
Takada A, Kawaoka Y.
Trends Microbiol . 1998 Jul;6(7):258-9. Review. No abstract available.
PMID: 9717212 Similar articles
Recombinant human monoclonal antibodies to Ebola virus.
Maruyama T, Parren PW, Sanchez A, Rensink I, Rodriguez LL, Khan AS, Peters CJ, Burton DR.
J Infect Dis . 1999 Feb;179 Suppl 1:S235-9.
PMID: 9988189 Similar articles Select item 12686428 62.
Comparison of the protective efficacy of DNA and baculovirus-derived protein vaccines for EBOLA virus in guinea pigs.
Mellquist-Riemenschneider JL, Garrison AR, Geisbert JB, Saikh KU, Heidebrink KD, Jahrling PB, Ulrich RG, Schmaljohn CS.
Virus Res . 2003 Apr;92(2):187-93.
PMID: 12686428 Similar articles Select item 12223058 63.
The role of DC-SIGN and DC-SIGNR in HIV and Ebola virus infection: can potential therapeutics block virus transmission and dissemination?
Baribaud F, Doms RW, Pöhlmann S.
Expert Opin Ther Targets . 2002 Aug;6(4):423-31. Review.
PMID: 12223058 Similar articles Select item 11485406 64.
Vaccine potential of Ebola virus VP24, VP30, VP35, and VP40 proteins.
Wilson JA, Bray M, Bakken R, Hart MK.
Virology . 2001 Aug 1;286(2):384-90.
PMID: 11485406 Free Article Similar articles Select item 12686432 65.
Vaccine for AIDS and Ebola virus infection.
Nabel GJ.
Virus Res . 2003 Apr;92(2):213-7. Review.
PMID: 12686432 Similar articles Select item 10544449 66.
[Effect of an infections dose of the Ebola virus on survivability and immunologic indicators in guinea pigs].
Dadaeva AA, Chepurnov AA, Sizikova LP, Chepurnova TS.
Vopr Virusol . 1999 Sep-Oct;44(5):217-20. Russian.
PMID: 10544449 Similar articles Select item 16597410 67.
[Ebola and Marburg viruses: the humans strike back].
Alazard-Dany N, Ottmann Terrangle M, Volchkov V.
Med Sci (Paris) . 2006 Apr;22(4):405-10. Review. French.
PMID: 16597410 Free Article Similar articles Select item 9278608 68.
Pathology of experimental Ebola virus infection in African green monkeys. Involvement of fibroblastic reticular cells.
Davis KJ, Anderson AO, Geisbert TW, Steele KE, Geisbert JB, Vogel P, Connolly BM, Huggins JW, Jahrling PB, Jaax NK.
Arch Pathol Lab Med . 1997 Aug;121(8):805-19.
PMID: 9278608 Similar articles Select item 9546777 69.
Two strings to the bow of Ebola virus.
Klenk HD, Volchkov VE, Feldmann H.
Nat Med . 1998 Apr;4(4):388-9. No abstract available.
PMID: 9546777 Similar articles Select item 17055127 70.
Protective efficacy of neutralizing antibodies against Ebola virus infection.
Takada A, Ebihara H, Jones S, Feldmann H, Kawaoka Y.
Vaccine . 2007 Jan 22;25(6):993-9. Epub 2006 Oct 10.
PMID: 17055127 Similar articles Select item 23165089 71.
Catheterized guinea pigs infected with Ebola Zaire virus allows safer sequential sampling to determine the pharmacokinetic profile of a phosphatidylserine-targeting monoclonal antibody.
Dowall S, Taylor I, Yeates P, Smith L, Rule A, Easterbrook L, Bruce C, Cook N, Corbin-Lickfett K, Empig C, Schlunegger K, Graham V, Dennis M, Hewson R.
Antiviral Res . 2013 Feb;97(2):108-11. doi: 10.1016/j.antiviral.2012.11.003. Epub 2012 Nov 16.
PMID: 23165089 Similar articles Select item 17940980 72.
Ebola virus-like particle-based vaccine protects nonhuman primates against lethal Ebola virus challenge.
Warfield KL, Swenson DL, Olinger GG, Kalina WV, Aman MJ, Bavari S.
J Infect Dis . 2007 Nov 15;196 Suppl 2:S430-7.
PMID: 17940980 Similar articles Select item 11160735 73.
Infectivity-enhancing antibodies to Ebola virus glycoprotein.
Takada A, Watanabe S, Okazaki K, Kida H, Kawaoka Y.
J Virol . 2001 Mar;75(5):2324-30.
PMID: 11160735 Free PMC Article Similar articles Select item 12229031 74.
[Ebola fever, an out of control epidemic?].
Zeller H.
Servir . 2002 May-Jun;50(3):132-5. Portuguese. No abstract available.
PMID: 12229031 Similar articles Select item 21987740 75.
Therapeutics of Ebola hemorrhagic fever: whole-genome transcriptional analysis of successful disease mitigation.
Yen JY, Garamszegi S, Geisbert JB, Rubins KH, Geisbert TW, Honko A, Xia Y, Connor JH, Hensley LE.
J Infect Dis . 2011 Nov;204 Suppl 3:S1043-52. doi: 10.1093/infdis/jir345.
PMID: 21987740 Similar articles Select item 25577809 76.
Ebola, dogs and a vaccine.
Jackson A.
Aust Vet J . 2014 Dec;92(12):N8. No abstract available.
PMID: 25577809 Similar articles Select item 27008735 77.
[EBOLA HEMORRHAGIC FEVER: DIAGNOSTICS, ETIOTROPIC AND PATHOGENETIC THERAPY, PREVENTION].
Zhdanov KV, Zakharenko SM, Kovalenko AN, Semenov AV, Fisun AY.
Klin Med (Mosk) . 2015;93(9):5-11. Review. Russian.
PMID: 27008735 Similar articles Select item 26563348 78.
Hình 10-11-12
British nurse makes "full recovery" from reactivated Ebola virus.
Murphy H.
BMJ . 2015 Nov 12;351:h6133. doi: 10.1136/bmj.h6133. No abstract available.
PMID: 26563348 Similar articles Select item 14762022 79.
Ebola vaccines tested in humans, monkeys.
Vastag B.
JAMA . 2004 Feb 4;291(5):549-50. No abstract available.
PMID: 14762022 Similar articles Select item 25391940 80.
Ethical dilemma for Ebola drug trials.
Hayden EC.
Nature . 2014 Nov 13;515(7526):177-8. doi: 10.1038/515177a. No abstract available.
PMID: 25391940 Similar articles
Infectious diseases. Ebola drugs still stuck in lab.
Enserink M.
Science . 2014 Jul 25;345(6195):364-5. doi: 10.1126/science.345.6195.364. No abstract available.
PMID: 25061181 Similar articles Select item 25390461 82.
Out of Africa--caring for patients with Ebola.
Rubin EJ, Baden LR.
N Engl J Med . 2014 Dec 18;371(25):2430-2. doi: 10.1056/NEJMe1412744. Epub 2014 Nov 12. No abstract available.
PMID: 25390461 Free Article Similar articles Select item 25852148 83.
Robust and sustained immune activation in human Ebola virus infection.
Mandl JN, Feinberg MB.
Proc Natl Acad Sci U S A . 2015 Apr 14;112(15):4518-9. doi: 10.1073/pnas.1503864112. Epub 2015 Apr 7. No abstract available.
PMID: 25852148 Free PMC Article Similar articles Select item 25673711 84.
Ebola virus disease in mice with transplanted human hematopoietic stem cells.
Lüdtke A, Oestereich L, Ruibal P, Wurr S, Pallasch E, Bockholt S, Ip WH, Rieger T, Gómez-Medina S, Stocking C, Rodríguez E, Günther S, Muñoz-Fontela C.
J Virol . 2015 Apr;89(8):4700-4. doi: 10.1128/JVI.03546-14. Epub 2015 Feb 11.
PMID: 25673711 Free PMC Article Similar articles Select item 25414285 85.
A dose of reality.
Cohen J, Kupferschmidt K.
Science . 2014 Nov 21;346(6212):908-11. doi: 10.1126/science.346.6212.908. No abstract available.
PMID: 25414285 Similar articles Select item 22191439 86.
Ebolavirus: a brief review of novel therapeutic targets.
Kondratowicz AS, Maury WJ.
Future Microbiol . 2012 Jan;7(1):1-4. doi: 10.2217/fmb.11.110. Review. No abstract available.
PMID: 22191439 Free Article Similar articles Select item 25470568 87.
Evaluating Ebola therapies--the case for RCTs.
Cox E, Borio L, Temple R.
N Engl J Med . 2014 Dec 18;371(25):2350-1. doi: 10.1056/NEJMp1414145. Epub 2014 Dec 3. No abstract available.
PMID: 25470568 Free Article Similar articles Select item 16929596 88.
[Hematological and immunological parameters during Ebola virus passages in guinea-pigs].
Dadaeva AA, Sizikova LP, Subbotina EL, Chepurnov AA.
Vopr Virusol . 2006 Jul-Aug;51(4):32-7. Russian.
PMID: 16929596 Similar articles Select item 25901439 89.
Treatment of Ebola.
Mehta AK, Lyon GM, Varkey JB.
N Engl J Med . 2015 Apr 23;372(17):1674. doi: 10.1056/NEJMc1500452. No abstract available.
PMID: 25901439 Free Article Similar articles Select item 25901440 90.
Treatment of Ebola.
Deen J, Dondorp AM, White NJ.
N Engl J Med . 2015 Apr 23;372(17):1673-4. doi: 10.1056/NEJMc1500452. No abstract available.
PMID: 25901440 Similar articles Select item 15455683 91.
[Functional activity of peritoneal macrophages in experimental Ebola fever].
Dadaeva AA, Sizikova LP, Chepurnov AA.
Vestn Ross Akad Med Nauk . 2004;(8):7-11. Russian.
PMID: 15455683 Similar articles Select item 29649305 92.
Disabling of lymphocyte immune response by Ebola virus.
Younan P, Iampietro M, Bukreyev A.
PLoS Pathog . 2018 Apr 12;14(4):e1006932. doi: 10.1371/journal.ppat.1006932. eCollection 2018 Apr. No abstract available.
PMID: 29649305 Free PMC Article Similar articles Select item 6108462 93.
Inactivated vaccine for Ebola virus efficacious in guineapig model.
Lupton HW, Lambert RD, Bumgardner DL, Moe JB, Eddy GA.
Lancet . 1980 Dec 13;2(8207):1294-5. No abstract available.
PMID: 6108462 Similar articles Select item 25722396 94.
Virology. Delineating Ebola entry.
Falzarano D, Feldmann H.
Science . 2015 Feb 27;347(6225):947-8. doi: 10.1126/science.aaa8121. No abstract available.
PMID: 25722396 Similar articles Select item 26582953 95.
Humanized Mice--A Neoteric Animal Disease Model for Ebola Virus?
Prescott J, Feldmann H.
J Infect Dis . 2016 Mar 1;213(5):691-3. doi: 10.1093/infdis/jiv539. Epub 2015 Nov 17. No abstract available.
PMID: 26582953 Free PMC Article Similar articles Select item 25282744 96.
[A question of competence].
Rausch R.
Med Monatsschr Pharm . 2014 Sep;37(9):313. German. No abstract available.
PMID: 25282744 Similar articles Select item 25370224 97.
False alarms give hospital staff practice in managing Ebola care.
Osborne K.
Nurs Stand . 2014 Nov 11;29(10):10. doi: 10.7748/ns.29.10.10.s9.
PMID: 25370224 Similar articles Select item 29952188 98.
[In process].
Tetsch L.
Med Monatsschr Pharm . 2017 Apr;40(4):182-4. German. No abstract available.
PMID: 29952188 Similar articles Select item 27612336 99.
"China 1 USA 0": A Former Ebola Provider's Explanation Why the United States is Falling Behind in the Global Health Arena.
Owens MD.
Mil Med . 2016 Sep;181(9):951-2. doi: 10.7205/MILMED-D-16-00203. No abstract available.
PMID: 27612336 Similar articles Select item 25751968 100.
Mice strains offer genetic clues.
[No authors listed]
Can Nurse . 2014 Dec;110(9):8. No abstract available.
PMID: 25751968 Similar articles
Infectious diseases. Ebola survivors fight back in plasma studies.
Enserink M.
Science . 2015 May 15;348(6236):742-3. doi: 10.1126/science.348.6236.742. No abstract available.
PMID: 25977529 Similar articles Select item 25920544 102.
Considerations regarding safe transport and transfer for Ebola patients in western countries.
Fusco FM, Puro V, Ippolito G.
Intensive Care Med . 2015 Jun;41(6):1175-6. doi: 10.1007/s00134-015-3825-y. Epub 2015 Apr 29. No abstract available.
PMID: 25920544Similar articles Select item 25690826 103.
Ebola: caring for pregnant and postpartum women and newborns in the United States: AWHONN practice brief number 3.
[No authors listed]
Nurs Womens Health . 2015 Feb-Mar;19(1):102-3. doi: 10.1111/1751-486X.12200. No abstract available.
PMID: 25690826 Similar articles Select item 25800581 104.
Pre-hospital transportation in Western countries for Ebola patients, comparison of guidelines.
Coignard-Biehler H, Isakov A, Stephenson J.
Intensive Care Med . 2015 Aug;41(8):1472-6. doi: 10.1007/s00134-015-3734-0. Epub 2015 Mar 24. No abstract available.
PMID: 25800581 Free PMC Article Similar articles Select item 25322506 105.
[Ebola: "survivors' blood" gets into the official therapeutic arsenal].
Nau JY.
Rev Med Suisse . 2014 Sep 17;10(442):1730-1. French. No abstract available.
PMID: 25322506 Similar articles Select item 25783286 106.
Suited, booted and ready to help.
Flaherty J.
Nurs Stand . 2015 Mar 18;29(29):64-5. doi: 10.7748/ns.29.29.64.s49.
PMID: 25783286 Similar articles Select item 9297348 107.
[Changes in certain indicators of hemostasis in rabbits upon administration of Ebola virus preparations].
Chepurnov AA, Dadaeva AA, Sizikova LP, Pisanko VA.
Vopr Virusol . 1997 May-Jun;42(3):140-3. Russian.
PMID: 9297348 Similar articles Select item 26148289 108.
Use of Life-Sustaining Therapies for Patients With Ebola Virus Disease.
Halpern SD, Emanuel EJ.
Ann Intern Med . 2015 Jul 7;163(1):70. doi: 10.7326/L15-5106-2. No abstract available.
PMID: 26148289 Similar articles Select item 26148288 109.
Use of Life-Sustaining Therapies for Patients With Ebola Virus Disease.
Berger JT.
Ann Intern Med . 2015 Jul 7;163(1):69-70. doi: 10.7326/L15-5106. No abstract available.
PMID: 26148288 Similar articles Select item 26170071 110.
The challenges of treating Ebola virus disease with experimental therapies.
Aoyama K, Fowler RA.
Lancet Respir Med . 2015 Jul;3(7):503-4. doi: 10.1016/S2213-2600(15)00237-4. No abstract available.
PMID: 26170071 Similar articles Select item 25483156 111.
Ebola virus disease: clinical care and patient-centred research.
Roberts I, Perner A.
Lancet . 2014 Dec 6;384(9959):2001-2. doi: 10.1016/S0140-6736(14)62316-3. No abstract available.
PMID: 25483156 Similar articles Select item 25647125 112.
A place at the table for children in the ebola virus disease discussion.
Remy KE, Chertow DS.
Pediatr Crit Care Med . 2015 Feb;16(2):184-5. doi: 10.1097/PCC.0000000000000368. No abstract available.
PMID: 25647125 Similar articles Select item 25398534 113.
Clinical trials of Ebola therapies to begin in December.
Gulland A.
BMJ . 2014 Nov 14;349:g6827. doi: 10.1136/bmj.g6827. No abstract available.
PMID: 25398534 Similar articles Select item 25602389 114.
65th AALAS National Meeting.
[No authors listed]
Lab Anim (NY) . 2015 Feb;44(2):51. doi: 10.1038/laban.691. No abstract available.
PMID: 25602389 Similar articles Select item 27125035 115.
Fièvre Ébola: "clinique".
Bricaire F.
Bull Acad Natl Med . 2014 Nov;198(8):1501-4. French. No abstract available.
PMID: 27125035 Similar articles Select item 25509447 116.
Can transfusions aid Ebola fight?
Johnson SR.
Mod Healthc . 2014 Nov 3;44(44):18. No abstract available.
PMID: 25509447 Similar articles